Without additional funding from Congress, the U.S. cannot secure sufficient COVID-19 vaccine boosters and variant-specific vaccines for all Americans; reimburse providers to test, treat and vaccinate the uninsured; provide monoclonal antibody therapies to states; or sustain testing capacity, among other actions, according to a White House announcement today. 

“Earlier this month, President Biden laid out a comprehensive plan to ensure that the country can continue to move forward safely and remain prepared to fight new variants and future surges of the virus. And the Administration has been clear that we need Congress to provide additional resources, including $22.5 billion in immediate emergency funding. Inaction will set us back in this fight, leave us less prepared, and cost us more lives,” the fact sheet states.
 

Related News Articles

Headline
In a study of symptomatic adults tested for SARS-CoV-2 at U.S. pharmacies since Sept. 14, bivalent COVID-19 vaccine boosters provided additional protection…
Headline
The Biden Administration today launched a six-week campaign to encourage Americans to get an updated COVID-19 vaccine. In addition to ongoing pop-up clinics,…
Headline
The Health Resources and Services Administration this week opened the Provider Relief Fund reporting portal through Dec. 2 for health care providers…
Headline
Five medical organizations this week released a toolkit for clinicians in post-acute and long-term care settings about the benefits of the COVID-19 bivalent…
Headline
Children under age 5 are more likely to receive a COVID-19 vaccine if their parents perceive it as safe and their health care provider recommends it, according…
Headline
AHA this week released a new Thanksgiving-focused toolkit to help promote pediatric COVID-19 vaccination on social media, including sample content and graphics…